Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / #OTHER
-
Shares outstanding
-
67,017,829
-
Total 13F shares
-
51,434,738
-
Share change
-
-875,081
-
Total reported value
-
$364,159,640
-
Put/Call ratio
-
91%
-
Price per share
-
$7.08
-
Number of holders
-
82
-
Value change
-
-$38,591,043
-
Number of buys
-
46
-
Number of sells
-
36
Institutional Holders of Generation Bio Co. - #OTHER (GBIO) as of Q4 2021
As of 31 Dec 2021,
Generation Bio Co. - #OTHER (GBIO) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,434,738 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, Atlas Venture Life Science Advisors, LLC, Bellevue Group AG, VANGUARD GROUP INC, FARALLON CAPITAL MANAGEMENT LLC, Artal Group S.A., Yiheng Capital Management, L.P., STATE STREET CORP, and Casdin Capital, LLC.
This page lists
81
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.